Front Public Health
August 2024
Objective: To explore the ramifications of the COVID-19 pandemic on Mental Health and Substance Use.
Patients And Methods: Relevant literature examining the correlation between COVID-19 and mental health/substance use was reviewed, and findings were summarized.
Results: Specific mechanisms regarding COVID-19's effects on the brain are unclear, but preliminary studies and biomarkers have been suggested in the literature.
Objective: This study began as a single-blind randomized controlled trial (RCT) to investigate the efficacy and safety of electroconvulsive therapy (ECT) for severe treatment-refractory agitation in advanced dementia. The aims are to assess agitation reduction using the Cohen-Mansfield Agitation Inventory (CMAI), evaluate tolerability and safety outcomes, and explore the long-term stability of agitation reduction and global functioning. Due to challenges encountered during implementation, including recruitment obstacles and operational difficulties, the study design was modified to an open-label format and other protocol amendments were implemented.
View Article and Find Full Text PDFBackground: Catatonia is a challenging and heterogeneous neuropsychiatric syndrome of motor, affective and behavioral dysregulation which has been associated with multiple disorders such as structural brain lesions, systemic diseases, and psychiatric disorders. This systematic review summarized and compared functional neuroimaging abnormalities in catatonia associated with psychiatric and medical conditions.
Methods: Using PRISMA methods, we completed a systematic review of 6 databases from inception to February 7th, 2024 of patients with catatonia that had functional neuroimaging performed.